Condition (MeSH)
Rhinitis, Vasomotor
ClinicalTrials.gov lists 12 trials for Rhinitis, Vasomotor or a narrower condition beneath it. GlaxoSmithKline has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
12 of the 12 trials are tagged with Rhinitis, Vasomotor itself; the rest are tagged with a narrower condition beneath it.
When did Rhinitis, Vasomotor trials start? (8)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Phase 4
- Not applicable
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 2 |
| 2020 | 1 |
| 2013 | 1 |
| 2011 | 1 |
| 2009 | 2 |
| 2006 | 1 |
| 2005 | 3 |
| 1998 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 12 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Rhinitis, Vasomotor trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 5 |
| Phase 4 | 1 |
| Not applicable | 6 |
How many Rhinitis, Vasomotor trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Completed | 10 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Rhinitis, Vasomotor trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| Alcon Research | 1 |
| Bayer | 1 |
| Hanmi Pharmaceutical Company Limited | 1 |
Interventions as named in the registry (11)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Fluticasone foroate | 2 |
| Pseudoephedrine / Levocetirizine | 1 |
| Acupuncture | 1 |
| Phenylephrine Hydrochloride (HCl) Extended Release (ER) Tablets 30 mg | 1 |
| Combined Intranasal Mometasone Furoate with oral Levocetirizine | 1 |
Showing 5 of 11 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Rhinitis, Vasomotor trials report? (1)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Nephrotic syndrome | 1 | 1 |
Which publications cover Rhinitis, Vasomotor? (12)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Surgical management of vasomotor rhinitis: a systematic review. | American journal of rhinology & allergy | 2015 | Yes |
| Overview of the treatment of allergic rhinitis and nonallergic rhinopathy. | Proceedings of the American Thoracic Society | 2011 | Yes |
| Impact of acupuncture on vasomotor rhinitis: a randomized placebo-controlled pilot study. | Journal of alternative and complementary medicine (New York, N.Y.) | 2009 | Yes |
| The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis. | American journal of otolaryngology | 2006 | Yes |
| Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study. | Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery | 2005 | Yes |
Showing 5 of 12 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.